SEC filing record
Primary Source · SEC.gov

OurCrowd (Investment in Biocatch) L.P.

Single-Deal SPV2024 vintage506(b), 3(c)(1)
Latest signalSold increasedForm D/A · 2024-03-123 events: 1 sold increased, 1 investors increased, 1 offering went indefiniteLast filing 2024-03-12

Raised

$13M

Investors

244

Min Invest

$10,000

Is this your company or fund? Claim this page free.

AltStreet Analysis

·

Generated from EDGAR primary sources

This is an amended Form D filing for OurCrowd (Investment in Biocatch) L.P., a single-deal special purpose vehicle organized in the British Virgin Islands that pools investor capital to invest in the company Biocatch. The fund has raised $13.0M from 244 investors at a $10K minimum investment, under combined 506(b) and 3(c)(1) exemptions, with Jonathan Medved, Andrew Kaye, Caleb Chill, and Robert Citron listed as executive officers/directors.

Within the alternative investment category, this vehicle represents a venture-style single-company SPV structure, a common format for aggregating smaller retail-adjacent checks (here averaging roughly $53K per investor) into a single portfolio company investment. The simultaneous use of 506(b) and 3(c)(1) exemptions and a relatively low $10K minimum are consistent with pooled, broadly-marketed venture syndication vehicles rather than traditional institutional funds.

Data Flags

exemptionFiling claims both 506(b) and 3(c)(1) exemptions simultaneously, which is somewhat atypical but consistent with pooled SPV structures used to aggregate many smaller investors into a single-company investment.
stateOfIncorporationEntity is domiciled in the British Virgin Islands, an offshore jurisdiction, despite filing a U.S. Form D — indicates a cross-border fund structure.
totalInvestors244 investors against a $13.0M raise implies an average check size of roughly $53K, modest relative to typical venture SPVs, though consistent with the stated $10K minimum.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001607653
Entity NameOurCrowd (Investment in Biocatch) L.P.
ExemptionRule 506(b), Section 3(c), Section 3(c)(1)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners.
Entity TypeLimited Partnership
Jurisdiction of OrganizationVirgin Islands, British
Issuer Address28 Derech Hebron, Jerusalem, Israel 9108001
Phone972-2-636-9300
Industry / Fund TypePooled Investment Fund · Venture Capital Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer)
Securities TypePooled Investment Fund
First Sale DateFebruary 20, 2018
Filing DateMarch 12, 2024
Accession Number0001607653-24-000001
Total Offering AmountIndefinite
Total Amount Sold$12,956,555
Total Investors244
Non-Accredited InvestorsNone
Minimum Investment$10,000
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeNo Revenues
State (Issuer Address)L3
Amendment Count3 amendments filed (4 Form D filings)

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

3

latest Mar 12, 2024

Critical / warning

0 / 0

2 watch · 1 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

3

lapsed

Latest event Sold increase · Mar 12, 2024

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Fund family Part of the OurCrowd family: 475 vehicles across 41 generations · adviser of record Strategic Investment Management, LLC, Ourcrowd · full family and the filing behind each link in the terminal

Investor

  • The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
  • 3 filing events with values and deltas, latest 2024-03-12, and alerts on the next one
  • 3 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Jonathan Medved

Executive Officer, Director · Jerusalem, L3

Andrew Kaye

Executive Officer, Director · Jerusalem, L3

Caleb Chill

Executive Officer · Jerusalem, L3

Robert Citron

Executive Officer · Jerusalem, L3

Questions About OurCrowd (Investment in Biocatch) L.P.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is OurCrowd (Investment in Biocatch) L.P.?

OurCrowd (Investment in Biocatch) L.P. is a Virgin Islands, British limited partnership that filed a Form D with the SEC on March 12, 2024 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests. AltStreet links the issuer to OurCrowd.

Is OurCrowd (Investment in Biocatch) L.P. legit?

AltStreet does not rate legitimacy; it reports the public record. OurCrowd (Investment in Biocatch) L.P. filed a Form D with the SEC on March 12, 2024 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $12,956,555 sold to 244 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. The issuer is linked to OurCrowd, which AltStreet has reviewed. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is OurCrowd (Investment in Biocatch) L.P. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that OurCrowd (Investment in Biocatch) L.P. claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has OurCrowd (Investment in Biocatch) L.P. raised?

OurCrowd (Investment in Biocatch) L.P. reported $12,956,555 sold from 244 investors in an offering of indefinite size as of the Form D filed March 12, 2024.

Who can invest in OurCrowd (Investment in Biocatch) L.P.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000.

What is the minimum investment in OurCrowd (Investment in Biocatch) L.P.?

The Form D lists $10,000 as the minimum investment accepted from any outside investor as of March 12, 2024. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling OurCrowd (Investment in Biocatch) L.P. and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind OurCrowd (Investment in Biocatch) L.P.?

The Form D lists 4 related persons: Jonathan Medved, executive officer, director (Mr. Medved is Managing Partner of the General Partner, OurCrowd International General Partner, LP); Andrew Kaye, executive officer, director (Mr. Kaye is Managing Partner of the General Partner); Caleb Chill, executive officer (Mr. Chill is Partner and General Counsel of the General Partner); Robert Citron, executive officer (Mr. Citron is CFO of the General Partner). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is OurCrowd (Investment in Biocatch) L.P. located?

The issuer's address on its SEC filings is 28 Derech Hebron, Jerusalem, Israel 9108001. Its phone number of record is 972-2-636-9300. It is organized under the laws of Virgin Islands, British.

How long is the OurCrowd (Investment in Biocatch) L.P. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 3 amendments are on record for this CIK.

How large is OurCrowd (Investment in Biocatch) L.P.?

The Form D reports a revenue range of No Revenues.

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Platform verification: the separate analyst-reviewed program for platforms, with right of reply and a document library.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.